Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidized low-density lipoprotein (Ox-LDL) refers to LDL particles that have undergone oxidative modification, primarily through the action of free radicals. This process alters both the lipid and protein components of LDL, resulting in a particle with pro-atherogenic properties. Ox-LDL is strongly associated with the development and progression of atherosclerosis, contributing to plaque formation in arterial walls by promoting inflammation, endothelial dysfunction, and foam cell formation.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidized Low-Density Lipoprotein (Ox-LDL).